Home Newsfeeds FDA Says Case-by-case Release Of Some Abbott Amino Acid-Based & Metabolic Infant Formula Has Provided Products To 2,958 Infants & Individuals In Need; Says To Date, ~500K Containers Of Additional Product Remain Accessible To Those In Need

General

FDA Says Case-by-case Release Of Some Abbott Amino Acid-Based & Metabolic Infant Formula Has Provided Products To 2,958 Infants & Individuals In Need; Says To Date, ~500K Containers Of Additional Product Remain Accessible To Those In Need

-Reuters

byBill Haddad

July 1, 2022

1 minute read

-Reuters

Netflix Crashes As ‘Stranger Things 4’ Volume 2 Goes Live: Was Vecna To Blame?

By Phil Hall

July 1, 10:19 AM

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

DIS

Zymeworks Announces Abstract For Zanidatamab In Late-Line HER2-Positive Hormone-Receptor Positive Metastatic Breast Cancer At The San Antonio Breast Cancer Symposium

By Benzinga Newsdesk

November 21, 10:07 AM

Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the publication of an abstract highlighting new clinical data for zanidatamab, a

ZYME